tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NTLA Stock Latest News

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesIntellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20h ago
NTLA
Cathie Wood’s ARK Investment bought 185K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment bought 185K shares of Intellia Therapeutics today
17d ago
NTLA
BlueAllele sues Intellia for patent infringement regarding ‘insertion templates’
PremiumThe Fly
BlueAllele sues Intellia for patent infringement regarding ‘insertion templates’
17d ago
NTLA
3 Best Stocks to Buy Now, 6/28/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 6/28/2024, According to Top Analysts
27d ago
MU
UAL
Intellia Therapeutics Welcomes New CFO, Announces Executive Transition
PremiumCompany Announcements
Intellia Therapeutics Welcomes New CFO, Announces Executive Transition
29d ago
8K
NTLA
Intellia Therapeutics Announces CFO Transition
PremiumPress ReleasesIntellia Therapeutics Announces CFO Transition
29d ago
NTLA
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
PremiumThe Fly
Intellia Therapeutics CFO Glenn Goddard to step down, Edward Dulac to succeed
29d ago
FATE
NTLA
Intellia reports proof-of-concept data for redosing CRISPR-based therapy
PremiumThe Fly
Intellia reports proof-of-concept data for redosing CRISPR-based therapy
30d ago
NTLA
REGN
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
PremiumPress Releases
Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
30d ago
NTLA
Alnylam ATTR data positive for Intellia’s NTLA-2001, says Truist
PremiumThe Fly
Alnylam ATTR data positive for Intellia’s NTLA-2001, says Truist
1M ago
ALNY
NTLA
Intellia Therapeutics to present data from patients redosed with NTLA-2001
PremiumThe Fly
Intellia Therapeutics to present data from patients redosed with NTLA-2001
1M ago
NTLA
Intellia Therapeutics to Present the First-Ever Clinical Data From Patients Redosed with an Investigational In Vivo CRISPR Gene Editing Therapy at the Peripheral Nerve Society Annual Meeting 2024
PremiumPress Releases
Intellia Therapeutics to Present the First-Ever Clinical Data From Patients Redosed with an Investigational In Vivo CRISPR Gene Editing Therapy at the Peripheral Nerve Society Annual Meeting 2024
1M ago
NTLA
Intellia Therapeutics Welcomes Brian Goff to Board of Directors
PremiumCompany AnnouncementsIntellia Therapeutics Welcomes Brian Goff to Board of Directors
1M ago
8K
NTLA
Intellia Therapeutics Names Brian Goff to its Board of Directors
PremiumPress Releases
Intellia Therapeutics Names Brian Goff to its Board of Directors
1M ago
NTLA
Intellia Therapeutics appoints Brian Goff to board of directors
PremiumThe Fly
Intellia Therapeutics appoints Brian Goff to board of directors
1M ago
AGIO
NTLA
Cathie Wood’s ARK Investment bought 47K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment bought 47K shares of Intellia Therapeutics today
1M ago
NTLA
Cathie Wood’s ARK Investment bought 137K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment bought 137K shares of Intellia Therapeutics today
2M ago
NTLA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AFMD
BPTH
Cathie Wood’s ARK Investment bought 174K shares of Intellia Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment bought 174K shares of Intellia Therapeutics today
2M ago
NTLA
Intellia announces long-term data from ongoing Phase 1 study of NTLA-2002
PremiumThe FlyIntellia announces long-term data from ongoing Phase 1 study of NTLA-2002
2M ago
NTLA
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
PremiumPress Releases
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
2M ago
NTLA
Intellia Therapeutics price target lowered to $29 from $31 at Citi
PremiumThe Fly
Intellia Therapeutics price target lowered to $29 from $31 at Citi
3M ago
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >